NYT: Psymposia Pushed Anti-Pharma Agenda to Sink MDMA Approval

February 6, 2025

A Bright Future for Psychedelics Under Trump?

November 13, 2024

Experts Urge Further Study on Psychotherapy’s Influence on MDMA Therapy

October 4, 2024

NRx Pharmaceuticals Completes 12 Months of Stability on First Commercial-Scale Lot of IV Ketamine

September 30, 2024

Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection

August 22, 2024

Cybin Holds ‘Productive’ Meeting with FDA to Discuss Plans for CYB003

August 21, 2024